Dr. Geoffrey L. Uy
Claim this profileWashington University School of Medicine
Expert in Acute Myelogenous Leukemia
Expert in Acute Myeloid Leukemia
28 reported clinical trials
63 drugs studied
About Geoffrey L. Uy
Education:
- Earned an MD from Washington University School of Medicine.
Experience:
- Over 21 years of clinical experience as an oncologist.
- Specializes in Oncology, with a subspecialty in Hematologic Oncology.
- Affiliated with Barnes-Jewish Hospital and Siteman Cancer Center.
- Recognized for exceptional patient care and high satisfaction ratings.
Area of expertise
1Acute Myelogenous Leukemia
Global LeaderFLT3 negative
FLT3 positive
CD7 positive
2Acute Myeloid Leukemia
Global LeaderFLT3 negative
FLT3 positive
CD7 positive
Affiliated Hospitals
Clinical Trials Geoffrey L. Uy is currently running
Dendritic Cells
for Graft-versus-Host Disease
Dendritic cells (DCs) serve as sentries for the immune system. DCs recognize foreign compounds (antigens) in the body, which they internalize and process. When DCs uptake foreign antigens, they migrate to secondary lymphoid organs, where the processed antigens are presented to T cells. Various DC subsets with unique cell lineages, surface protein markers, and tissue localization determinants have been identified. For example, Langerhans cells (LCs) and interstitial dendritic cells (intDCs) are DCs found in stratified epithelia, such as the skin. Though both are expressed in the skin, they differ with respect to their origin and surface protein content and can activate distinct types of immune responses. They may also have different specificities for the capture of antigens and presentation to circulating T cells. To date, it is unknown what role, if any, the different DC populations that reside or repopulate in the skin play in the development and progression of skin graft-versus-host disease (GVHD) following bone marrow transplant.
Recruiting1 award N/A3 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Geoffrey L. Uy
Clinical Trial Related2 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Geoffrey L. Uy has experience with
- Cytarabine
- Cyclophosphamide
- Dexamethasone
- Uproleselan
- Cytokine Induced Memory-like NK Cell Adoptive Therapy
- Isatuximab
Breakdown of trials Geoffrey L. Uy has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
Myelodysplastic Syndrome
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Geoffrey L. Uy specialize in?
Geoffrey L. Uy focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 negative patients, or patients who are FLT3 positive.
Is Geoffrey L. Uy currently recruiting for clinical trials?
Yes, Geoffrey L. Uy is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Geoffrey L. Uy has studied deeply?
Yes, Geoffrey L. Uy has studied treatments such as Cytarabine, Cyclophosphamide, Dexamethasone.
What is the best way to schedule an appointment with Geoffrey L. Uy?
Apply for one of the trials that Geoffrey L. Uy is conducting.
What is the office address of Geoffrey L. Uy?
The office of Geoffrey L. Uy is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.